PARM1 抗体 (AA 201-310)
Quick Overview for PARM1 抗体 (AA 201-310) (ABIN872651)
抗原
See all PARM1 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 201-310
-
预测反应
- Human
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human Cipar1
-
亚型
- IgG
-
-
-
-
应用备注
-
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
有效期
- 12 months
-
-
- PARM1 (Prostate Androgen-Regulated Mucin-Like Protein 1 (PARM1))
-
别名
- Cipar1
-
背景
-
Synonyms: Alternative namesCastration induced prostatic apoptosis related protein 1, Cipar 1, Cipar-1, Prostatic androgen repressed message 1 protein, Protein PARM 1 Precursor,PARM1_HUMAN.
Background: Cipar1 may be involved in a survival program enabling certain prostatic cells to resist apoptosis. It is expressed in prostate and detected in other organs at low levels, these include the heart and various tissues of the urogenital tract, not detected in mammary gland.
抗原
-